179 related articles for article (PubMed ID: 15843667)
1. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.
Cannon CP; Braunwald E; McCabe CH; Grayston JT; Muhlestein B; Giugliano RP; Cairns R; Skene AM;
N Engl J Med; 2005 Apr; 352(16):1646-54. PubMed ID: 15843667
[TBL] [Abstract][Full Text] [Related]
2. Azithromycin for the secondary prevention of coronary events.
Grayston JT; Kronmal RA; Jackson LA; Parisi AF; Muhlestein JB; Cohen JD; Rogers WJ; Crouse JR; Borrowdale SL; Schron E; Knirsch C;
N Engl J Med; 2005 Apr; 352(16):1637-45. PubMed ID: 15843666
[TBL] [Abstract][Full Text] [Related]
3. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
[TBL] [Abstract][Full Text] [Related]
4. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Cannon CP; Braunwald E; McCabe CH; Rader DJ; Rouleau JL; Belder R; Joyal SV; Hill KA; Pfeffer MA; Skene AM;
N Engl J Med; 2004 Apr; 350(15):1495-504. PubMed ID: 15007110
[TBL] [Abstract][Full Text] [Related]
5. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
Roe MT; Armstrong PW; Fox KA; White HD; Prabhakaran D; Goodman SG; Cornel JH; Bhatt DL; Clemmensen P; Martinez F; Ardissino D; Nicolau JC; Boden WE; Gurbel PA; Ruzyllo W; Dalby AJ; McGuire DK; Leiva-Pons JL; Parkhomenko A; Gottlieb S; Topacio GO; Hamm C; Pavlides G; Goudev AR; Oto A; Tseng CD; Merkely B; Gasparovic V; Corbalan R; Cinteză M; McLendon RC; Winters KJ; Brown EB; Lokhnygina Y; Aylward PE; Huber K; Hochman JS; Ohman EM;
N Engl J Med; 2012 Oct; 367(14):1297-309. PubMed ID: 22920930
[TBL] [Abstract][Full Text] [Related]
6. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ
Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042
[TBL] [Abstract][Full Text] [Related]
7. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial.
Cercek B; Shah PK; Noc M; Zahger D; Zeymer U; Matetzky S; Maurer G; Mahrer P;
Lancet; 2003 Mar; 361(9360):809-13. PubMed ID: 12642046
[TBL] [Abstract][Full Text] [Related]
8. Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events.
Berg HF; Maraha B; Scheffer GJ; Quarles-van Ufford M; Vandenbroucke-Grauls CM; Peeters MF; Kluytmans JA
Clin Infect Dis; 2005 Feb; 40(3):358-65. PubMed ID: 15668857
[TBL] [Abstract][Full Text] [Related]
9. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
[TBL] [Abstract][Full Text] [Related]
10. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).
Stone AF; Mendall MA; Kaski JC; Edger TM; Risley P; Poloniecki J; Camm AJ; Northfield TC
Circulation; 2002 Sep; 106(10):1219-23. PubMed ID: 12208796
[TBL] [Abstract][Full Text] [Related]
11. Rovamycine as add-on treatment in unstable angina and 4 year evolution with major cardiovascular events.
Rădoi M; Bobescu E; Agache I
Rom J Intern Med; 2003; 41(3):237-46. PubMed ID: 15526507
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
13. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E
J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923
[TBL] [Abstract][Full Text] [Related]
14. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
O'Connor CM; Dunne MW; Pfeffer MA; Muhlestein JB; Yao L; Gupta S; Benner RJ; Fisher MR; Cook TD;
JAMA; 2003 Sep; 290(11):1459-66. PubMed ID: 13129985
[TBL] [Abstract][Full Text] [Related]
15. Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial.
Berg HF; Maraha B; van der Zee A; Gielis SK; Roholl PJ; Scheffer GJ; Peeters MF; Kluytmans JA
J Clin Microbiol; 2005 Mar; 43(3):1325-9. PubMed ID: 15750103
[TBL] [Abstract][Full Text] [Related]
16. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.
Mosorin M; Juvonen J; Biancari F; Satta J; Surcel HM; Leinonen M; Saikku P; Juvonen T
J Vasc Surg; 2001 Oct; 34(4):606-10. PubMed ID: 11668312
[TBL] [Abstract][Full Text] [Related]
17. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials.
Andraws R; Berger JS; Brown DL
JAMA; 2005 Jun; 293(21):2641-7. PubMed ID: 15928286
[TBL] [Abstract][Full Text] [Related]
18. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity.
Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
Circulation; 2004 Mar; 109(8):1010-5. PubMed ID: 14769704
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
Bønaa KH; Njølstad I; Ueland PM; Schirmer H; Tverdal A; Steigen T; Wang H; Nordrehaug JE; Arnesen E; Rasmussen K;
N Engl J Med; 2006 Apr; 354(15):1578-88. PubMed ID: 16531614
[TBL] [Abstract][Full Text] [Related]
20. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study.
Muhlestein JB; Anderson JL; Carlquist JF; Salunkhe K; Horne BD; Pearson RR; Bunch TJ; Allen A; Trehan S; Nielson C
Circulation; 2000 Oct; 102(15):1755-60. PubMed ID: 11023928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
